CD1D and neoplasm: iNKT cells, recognizing CD1d molecules on tumor cell surfaces, trigger cytotoxic responses that eliminate tumor cells and concurrently enhance the effectiveness of chemotherapeutic agents (Fallarini et al., 2012).